SMarT Minds Dx Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$100K
- Investors
-
1
SMarT Minds Dx General Information
Description
Developer of blood-based diagnostic technology designed for early Alzheimer's disease detection. The company's platform utilizes proprietary antibodies and assays to identify preclinical biomarkers and biological disease stages through non-invasive testing, enabling clinicians to monitor therapeutic responses and implement early intervention strategies using existing laboratory infrastructure.
Contact Information
Website
www.smartmindsdx.com.auCorporate Office
- Sydney, New South Wales
- Australia
Corporate Office
- Sydney, New South Wales
- Australia
SMarT Minds Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 15-Oct-2026 | $100K | Completed | Generating Revenue |
SMarT Minds Dx Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UNSW Founders | Accelerator/Incubator |
SMarT Minds Dx FAQs
-
Where is SMarT Minds Dx headquartered?
SMarT Minds Dx is headquartered in Sydney, Australia.
-
What industry is SMarT Minds Dx in?
SMarT Minds Dx’s primary industry is Diagnostic Equipment.
-
Is SMarT Minds Dx a private or public company?
SMarT Minds Dx is a Private company.
-
What is SMarT Minds Dx’s current revenue?
The current revenue for SMarT Minds Dx is .
-
How much funding has SMarT Minds Dx raised over time?
SMarT Minds Dx has raised $100K.
-
Who are SMarT Minds Dx’s investors?
UNSW Founders has invested in SMarT Minds Dx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process